Document is current
Any future updates will be listed below
-
Authors
Rosenblad, Andreas Karlsson https://orcid.org/0000-0003-3691-8326
Hashim, Bassam Mazin https://orcid.org/0009-0006-8775-9774
Lindblad, Per https://orcid.org/0000-0003-1217-4289
Ljungberg, Börje https://orcid.org/0000-0002-4121-3753
,
Dragomir, Anca
Kjellman, Anders
Scholtz, Bianca
Dahlin, Britt-Inger
Mangelus, Emma
Ulvskog, Emma
Pettersson, Linn
Lindskog, Magnus
Thomasson, Marcus
Johansson, Martin
Hellström, Mikael
Skoglund, Per
Sundqvist, Pernilla
Isaksson, Sigrid
Bonn, Stephanie
Holst, Susanna
Lundstam, Sven
Harmenberg, Ulrika
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 29 September 2024
First Online: 4 November 2024
Declarations
:
: Andreas Karlsson Rosenblad, No conflict of interest; Bassam Mazin Hashime: No conflict of interest.; Per Lindblad: No conflict of interest.; Börje Ljungberg: Company speaker honorarium: Pfizer, IPSEN, Trial participation: Jenssen—Astellas—Medivation, Company consultant: Ipsen, Other: EAU.
